Fluticasone propionate intranasal (Paratek Pharmaceuticals)

鼻内用丙酸氟替卡松 (Paratek Pharmaceuticals)

Report date: 2025/07/22 17:53:37

Base Information

Drug NameFluticasone propionate intranasal (Paratek Pharmaceuticals)
Drug Alias NameOPTINOSEOptiNose fluticasone propionateXHANCEFLU-EDSOPN-375 +[6] 
ClassificationSmall molecules > Steroids
Mechanisms of ActionGlucocorticoid receptor agonists
TargetsGlucocorticoid receptor
Therapy Area/IndicationsNasal PolypsSinusitis
Global Approved IndicationsNasal Polyps
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2017/09/18
Country/TerritoryCzechiaBulgariaCanada +[13] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesOptinose As
China Registration ClassN/A

Develop Information

Active CompaniesParatek PharmaceuticalOptinose Us Inc
Inactive CompaniesN/A
Active IndicationsNasal PolypsSinusitis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A